Amarin | AMRN - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
DBV Technologies USD 39.5M 1.44M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06